Regulation of NKT cell development and function by c-Myb
Regulation of NKT cell development and function by c-Myb
批准号:
7880388
负责人:
Jose Alberola-Ila
金额:
$24.45万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2012-02-29
关键词:
Adoptive TransferAntigensAntsAtherosclerosisAutoimmune DiseasesAutoimmune ProcessAutoimmunityBreedingCell Adhesion MoleculesCell Differentiation processCellsCharacteristicsCommunicable DiseasesCuesDNA Sequence RearrangementDataDefectDendritic CellsDevelopmentDiabetes MellitusDiseaseFamilyGenerationsGenesGeneticGlycolipidsGrantHalf-LifeHematopoiesisHematopoieticHistocompatibility Antigens Class IHomeostasisHourHypersensitivityImmune responseImmune systemIn VitroKnowledgeLupusLymphocyte SubsetMYB geneMalignant NeoplasmsMolecularMusNatural Killer CellsPathogenesisPhenotypePlayProcessProductionProto-Oncogene Proteins c-mybRegulationRetroviridaeRoleRunningSecondary toSignal PathwaySignal TransductionT-LymphocyteT-Lymphocyte SubsetsTamoxifenTestingTimeTransgenic MiceTransgenic OrganismsTumor Immunitybehavior influencecancer therapychemokinecytokinecytotoxicin vivomacrophagemembermicrobialneutrophilpathogenpublic health relevanceresearch studyresponsethymocytetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NKT cells represent a distinct subset of T lymphocytes that recognize glycolipid antigens presented by the nonclassical MHC class I molecule CD1d. Antigen recognition by NKT cells results in a "cytokine storm"; the secretion, within hours, of large quantities of Th1 and Th2 cytokines and chemokines, reminiscent of innate rather than adaptive functions. Through this cytokine and chemokine production, NKT cells influence the behavior of many other cells in the immune system, including NK cells, macrophages, other 12 T cells, dendritic cells and neutrophiles, and have been implicated in multiple processes, including microbial immunity, and tumor rejection. Similarly, they seem to play a role in the pathogenesis of autoimmune processes, atherosclerosis and allergy. Our results demonstrate that c-Myb, a transcription factor that plays multiple roles in hematopoiesis, is a critical player in NKT cell development. Inducible deletion of c-Myb in DP thymocytes results in a complete blockade in NKT cell development, previous to positive selection. Preliminary evidence suggests that different mechanisms may be responsible for this effect. c-Myb: thymocytes have a shortened half-life, have defects in TcR1 rearrangement -that may be secondary to the defect in half-life- and have defects in the expression of members of the SLAM/SAP signaling pathway, which is required for NKT cell positive selection. In aim one of this grant we propose experiments to analyze in detail the contributions of these mechanisms to the final phenotype of c-Myb: thymocytes. In aim two we will delete c-Myb from mature NKT cells and analyze its contribution to mature NKT cell homeostasis and function.
PUBLIC HEALTH RELEVANCE: NKT cells are a distinct subset of lymphocytes that play an important role in immune responses against pathogens. Alterations in their function may play a role in the pathogenesis of autoimmune disorders such as lupus or diabetes, as well as in atherosclerosis. This project will analyze the role of c-Myb, a transcription factor, in the development and function of NKT cells. A better understanding of these processes may offer clues to their manipulation during disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Flow Cytometry Core
-
批准号:10090977
-
项目类别:
-
资助金额:$11.8万
-
财政年份:2021
-
负责人:Jose Alberola-Ila
-
依托单位:
Flow Cytometry Core
-
批准号:10571891
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2021
-
负责人:Jose Alberola-Ila
-
依托单位:
Flow Cytometry Core
-
批准号:10339348
-
项目类别:
-
资助金额:$11.8万
-
财政年份:2021
-
负责人:Jose Alberola-Ila
-
依托单位:
Characterization of a distinct NKT subset and its role in influenza responses
-
批准号:10392859
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2018
-
负责人:Jose Alberola-Ila
-
依托单位:
Characterization of a distinct NKT subset and its role in influenza responses
-
批准号:9900716
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2018
-
负责人:Jose Alberola-Ila
-
依托单位:
Characterization of a distinct NKT subset and its role in influenza responses
-
批准号:10132967
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2018
-
负责人:Jose Alberola-Ila
-
依托单位:
E protein activity regulates effector lineage differentiation of NKT and ILCs
-
批准号:9247132
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2016
-
负责人:Jose Alberola-Ila
-
依托单位:
Hematopoietic Stem Cell Senescence
-
批准号:8077422
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2010
-
负责人:Jose Alberola-Ila
-
依托单位:
Hematopoietic Stem Cell Senescence
-
批准号:7862098
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2010
-
负责人:Jose Alberola-Ila
-
依托单位:
Hematopoietic Stem Cell Senescence
-
批准号:8269672
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2010
-
负责人:Jose Alberola-Ila
-
依托单位:
Regulation of NKT cell development and function by c-Myb
-
批准号:8032491
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2010
-
负责人:Jose Alberola-Ila
-
依托单位:
Hematopoietic Stem Cell Senescence
-
批准号:8471764
-
项目类别:
-
资助金额:$39.58万
-
财政年份:2010
-
负责人:Jose Alberola-Ila
-
依托单位:
Role of GATA-3 During CD4/CD8 Lineage Commitment
-
批准号:6984842
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2004
-
负责人:Jose Alberola-Ila
-
依托单位:
Role of GATA-3 During CD4/CD8 Lineage Commitment
-
批准号:7169553
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2004
-
负责人:Jose Alberola-Ila
-
依托单位:
Role of GATA-3 During CD4/CD8 Lineage Commitment
-
批准号:7534362
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2004
-
负责人:Jose Alberola-Ila
-
依托单位:
Role of GATA-3 During CD4/CD8 Lineage Commitment
-
批准号:7325682
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2004
-
负责人:Jose Alberola-Ila
-
依托单位:
Role of GATA-3 During CD4/CD8 Lineage Commitment
-
批准号:6870051
-
项目类别:
-
资助金额:$35.84万
-
财政年份:2004
-
负责人:Jose Alberola-Ila
-
依托单位:
ROLE OF RAS IN T-CELL FATE DETERMINATION
-
批准号:6497323
-
项目类别:
-
资助金额:$27.85万
-
财政年份:2000
-
负责人:Jose Alberola-Ila
-
依托单位:
ROLE OF RAS IN T-CELL FATE DETERMINATION
-
批准号:6349903
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2000
-
负责人:Jose Alberola-Ila
-
依托单位:
ROLE OF RAS IN T-CELL FATE DETERMINATION
-
批准号:6696235
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2000
-
负责人:Jose Alberola-Ila
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: